Lanean...
Getting personal with myelodysplastic syndromes: is now the right time?
INTRODUCTION: Commonly used scoring systems rely on blood counts, histological and cytological examination of bone marrow and peripheral blood, and cytogenetic assessments to estimate prognosis of patients with myelodysplastic syndromes (MDS) and guide therapy decisions. Next generation sequencing (...
Gorde:
| Argitaratua izan da: | Expert Rev Hematol |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540985/ https://ncbi.nlm.nih.gov/pubmed/30977414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2019.1592673 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|